APEPTICO is a biotech company developing new peptide-based medicinal drugs for the treatment of severe and chronic diseases.
APEPTICO is an innovative biotech company that develops new peptide-based medicinal drugs for the therapeutic and prophylactic treatment of severe and chronic diseases.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 5, 2010 | Series A | $3.95M | 1 |
BioScience Ventures Group
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
BioScience Ventures Group
|
Yes | Series A |